홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Sodium Bicarbonate → N,N'-(4,4'-biphenyldiylbis(1H-imidazole-4,2-diyl(2S)-2,1-pyrrolidinediyl((2S)-3-methyl-1-oxo-1,2-butanediyl)))bis(1,3-thiazol-2-amine)

HRID 1873918
인쇄

반응식

HRID 1873918 반응식
[CH3:1][CH:2]([CH3:37])[C@H:3]([NH:31][C:32]1[S:33][CH:34]=[CH:35][N:36]=1)[C:4]([N:6]1[CH2:10][CH2:9][CH2:8][C@H:7]1[C:11]1[NH:12][C:13]([C:16]2[CH:21]=[CH:20][C:19](B3OC(C)(C)C(C)(C)O3)=[CH:18][CH:17]=2)=[CH:14][N:15]=1)=[O:5].Br[C:39]1[CH:44]=[CH:43][C:42]([C:45]2[NH:49][C:48]([C@@H:50]3[CH2:54][CH2:53][CH2:52][N:51]3[C:55](=[O:66])[C@@H:56]([NH:60][C:61]3[S:62][CH:63]=[CH:64][N:65]=3)[CH:57]([CH3:59])[CH3:58])=[N:47][CH:46]=2)=[CH:41][CH:40]=1.C([O-])(O)=O.[Na+]>COCCOC.O.C1C=CC([P]([Pd]([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)[P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1>[C:19]1([C:39]2[CH:44]=[CH:43][C:42]([C:45]3[N:49]=[C:48]([C@@H:50]4[CH2:54][CH2:53][CH2:52][N:51]4[C:55](=[O:66])[C@@H:56]([NH:60][C:61]4[S:62][CH:63]=[CH:64][N:65]=4)[CH:57]([CH3:59])[CH3:58])[NH:47][CH:46]=3)=[CH:41][CH:40]=2)[CH:20]=[CH:21][C:16]([C:13]2[N:12]=[C:11]([C@@H:7]3[CH2:8][CH2:9][CH2:10][N:6]3[C:4](=[O:5])[C@@H:3]([NH:31][C:32]3[S:33][CH:34]=[CH:35][N:36]=3)[CH:2]([CH3:37])[CH3:1])[NH:15][CH:14]=2)=[CH:17][CH:18]=1
참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트

참가 물질

7

반응물 3

HCID 516892Sodium BicarbonateHCID 57610899(S)-3-methyl-1-((S)-2-(5-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-2-(thiazol-2-ylamino)butan-1-oneHCID 57610917(S)-1-((S)-2-(5-(4-bromophenyl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-2-(thiazol-2-ylamino)butan-1-one

생성물 1

HCID 178448313
N,N'-(4,4'-biphenyldiylbis(1H-imidazole-4,2-diyl(2S)-2,1-pyrrolidinediyl((2S)-3-methyl-1-oxo-1,2-butanediyl)))bis(1,3-thiazol-2-amine)
수율 2%

시약·촉매·용매 3

HCID 178418397HCID 178418397, 화합물촉매HCID 962Water용매HCID 80711,2-Dimethoxyethane용매

반응 조건

온도
80 °C

실험 절차

A mixture of (S)-3-methyl-1-((S)-2-(5-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-2-(thiazol-2-ylamino)butan-1-one (275 mg, 0.527 mmol), (S)-1-((S)-2-(5-(4-bromophenyl)-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-2-(thiazol-2-ylamino)butan-1-one (250 mg, 0.527 mmol), NaHCO3 (133 mg, 1.582 mmol) and Pd(Ph3P)4 (60.9 mg, 0.053 mmol) in DME (3 mL) and Water (1 mL) was degassed by passing a stream of N2 through the mixture. The vessel was sealed and the reaction was heated at 80° C. overnight. The reaction mixture was diluted with H2O and extracted with EtOAc containing ca. 5% MeOH (×3). The combined org layers were concentrated, dissolved in MeOH and loaded onto an MCX cartridge. The cartridge was washed with MeOH and then NH3 in MeOH (2M). The appropriate fractions were concentrated in vacuo and the residue was purified by prep HPLC (CH3CN—H2O—NH4OAc). The material was purified by column chromatography (biotage) eluting with 0 to 20% MeOH in EtOAc. Further purification by prep HPLC (CH3CN—H2O—NH4OAc) followed by lyophilization afforded the title compound as a colorless solid (6.9 mg, 2%).

후처리

  1. customwas degassed
  2. customThe vessel was sealed
  3. additionThe reaction mixture was diluted with H2O
  4. extractionextracted with EtOAc containing ca. 5% MeOH (×3)
  5. concentrationThe combined org layers were concentrated
  6. dissolutiondissolved in MeOH
  7. washThe cartridge was washed with MeOH
  8. concentrationThe appropriate fractions were concentrated in vacuo
  9. customthe residue was purified by prep HPLC (CH3CN—H2O—NH4OAc)
  10. customThe material was purified by column chromatography (biotage)
  11. washeluting with 0 to 20% MeOH in EtOAc
  12. customFurther purification by prep HPLC (CH3CN—H2O—NH4OAc)

출처 및 근거

ORD 기록
ord-0b67b6000af143eca3cb7a5c69834add
출처 데이터셋
uspto-grants-2012_11
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08303944B2

반응 노트

이 페이지에서참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트